CA2022420A1 - Vaccin contre escherichia coli - Google Patents

Vaccin contre escherichia coli

Info

Publication number
CA2022420A1
CA2022420A1 CA2022420A CA2022420A CA2022420A1 CA 2022420 A1 CA2022420 A1 CA 2022420A1 CA 2022420 A CA2022420 A CA 2022420A CA 2022420 A CA2022420 A CA 2022420A CA 2022420 A1 CA2022420 A1 CA 2022420A1
Authority
CA
Canada
Prior art keywords
escherichia coli
coli vaccine
found
toxin
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2022420A
Other languages
English (en)
Other versions
CA2022420C (fr
Inventor
Johannes F. Van Den Bosch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2022420A1 publication Critical patent/CA2022420A1/fr
Application granted granted Critical
Publication of CA2022420C publication Critical patent/CA2022420C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002022420A 1989-08-18 1990-08-01 Vaccin contre escherichia coli Expired - Lifetime CA2022420C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89.202110.6 1989-08-18
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
CA2022420A1 true CA2022420A1 (fr) 1991-02-19
CA2022420C CA2022420C (fr) 2000-03-28

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022420A Expired - Lifetime CA2022420C (fr) 1989-08-18 1990-08-01 Vaccin contre escherichia coli

Country Status (16)

Country Link
US (1) US5750115A (fr)
EP (1) EP0413378B1 (fr)
JP (1) JP3031561B2 (fr)
KR (1) KR0177510B1 (fr)
CN (1) CN1062605C (fr)
AU (1) AU635062B2 (fr)
CA (1) CA2022420C (fr)
DE (1) DE69016129T2 (fr)
DK (1) DK0413378T3 (fr)
ES (1) ES2070266T3 (fr)
GR (1) GR3015782T3 (fr)
HU (2) HU210965B (fr)
IL (1) IL95175A (fr)
NZ (1) NZ234933A (fr)
TW (1) TW204353B (fr)
ZA (1) ZA906100B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
CA2289760A1 (fr) * 1997-05-16 1998-11-19 Medical Defense Technologies, Llc. Vaccin dirige contre les noyaux de lipopolysaccharides
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
WO1999059626A1 (fr) * 1998-05-15 1999-11-25 Mkb Investments Limited Partnership Composition et procede d'immunisation de volaille
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
AU2006287110B2 (en) 2005-08-30 2012-04-12 Commonwealth Scientific And Industrial Research Organisation Bacterial delivery of biologically active polypeptides
JP6199557B2 (ja) 2009-10-12 2017-09-20 ニュー ヘルス サイエンシーズ、インク．Ｎｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 酸素及び二酸化炭素の減損能力をもつ血液保存袋システム及び減損装置
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
JP2013507447A (ja) 2009-10-12 2013-03-04 ニュー ヘルス サイエンシーズ、インク． 酸素減損装置及び赤血球から酸素を除去する方法
EP4091645A1 (fr) 2010-08-25 2022-11-23 Hemanext Inc. Procédé d'amélioration de la qualité et de la survie des globules rouges pendant le stockage
EP4218412A1 (fr) 2010-11-05 2023-08-02 Hemanext Inc. Irradiation de globules rouges et stockage anaérobie
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
WO2013009843A1 (fr) * 2011-07-11 2013-01-17 Camas Incorporated Compositions contre des toxines bactériennes
PT3533507T (pt) 2011-08-10 2022-07-25 Hemanext Inc Dispositivo de filtragem integrado para depleção de leucócitos, oxigénio e/ou co2 e separação de plasma
US9877476B2 (en) 2013-02-28 2018-01-30 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
JP6997622B2 (ja) 2015-03-10 2022-02-04 ヘマネクスト インコーポレイテッド 使い捨ての酸素低減キット、器具及びそれらの使用方法
JP7175611B2 (ja) 2015-04-23 2022-11-21 ヘマネクスト インコーポレイテッド 嫌気性血液保存容器
EP3297641A4 (fr) 2015-05-18 2019-02-06 New Health Sciences, Inc. Procédés pour le stockage de sang total et compositions correspondantes
CN109195632A (zh) 2016-05-27 2019-01-11 新健康科学股份有限公司 厌氧血液储存和病原体失活方法
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4886748A (en) * 1986-03-11 1989-12-12 Shionogi & Co., Ltd. DNA encoding flagellin and vector having the same

Also Published As

Publication number Publication date
DE69016129T2 (de) 1995-05-24
HU210965B (en) 1995-09-28
HUT59612A (en) 1992-06-29
AU635062B2 (en) 1993-03-11
ES2070266T3 (es) 1995-06-01
HU905053D0 (en) 1991-01-28
CN1062605C (zh) 2001-02-28
KR0177510B1 (ko) 1999-03-20
CN1049523A (zh) 1991-02-27
NZ234933A (en) 1992-06-25
TW204353B (fr) 1993-04-21
EP0413378B1 (fr) 1995-01-18
IL95175A0 (en) 1991-06-10
ZA906100B (en) 1991-05-29
EP0413378A1 (fr) 1991-02-20
DK0413378T3 (da) 1995-05-15
AU6109990A (en) 1991-02-21
HU211827A9 (en) 1995-12-28
JP3031561B2 (ja) 2000-04-10
GR3015782T3 (en) 1995-07-31
KR910004209A (ko) 1991-03-28
DE69016129D1 (de) 1995-03-02
JPH03184996A (ja) 1991-08-12
CA2022420C (fr) 2000-03-28
US5750115A (en) 1998-05-12
IL95175A (en) 1994-05-30

Similar Documents

Publication Publication Date Title
CA2022420A1 (fr) Vaccin contre escherichia coli
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
CY2612B2 (en) Compounds for immunotherapy and diagnosis of tuberculosis
MX9702955A (es) Vacuna y antitoxina para tratamiento y prevencion de enfermedad c. difficile.
EP1731166A3 (fr) Protéines et vaccins de streptococcus pneumoniae
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
CA2014033A1 (fr) Compositions et traitement contre la pneumonie chez les animaux
CA2145397A1 (fr) Vaccins conjugues polysaccharides-proteines contre des streptocoques du groupe b de types ii et v
CA2154063A1 (fr) Traitement de troubles gastroduodenaux associes a h. pylori
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
CA2123222A1 (fr) Vaccins contre des bacteries a gram negatif
TW275632B (fr)
ES477212A1 (es) Un procedimiento para la preparacion de una enterotoxina.
ATE157258T1 (de) Zubereitungen und behandlungen von pneumonia in tieren
DK0484438T3 (da) Biologisk præparat og dets anvendelse
CA2109977A1 (fr) Vaccin giardia
EP0028172A3 (en) Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains
CA2097702A1 (fr) Vaccin contre les dermatophyties
CA2133108A1 (fr) Vaccin a base de toxoide contre pasteurella haemolytica type a-1
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
CA2128247A1 (fr) Vaccins bases sur la streptokinase
IL122829A (en) Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
GB9303681D0 (en) Vaccines

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry